Serum Talin-1 and Cripto-1 in Colorectal Cancer
ConditionColo-rectal Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
The goals of this study are
* To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls. * To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA
Eligibility criteria
Qualifiers
Age >18 years Old.
Patients of both sexes who met the clinical diagnostic criteria of colorectal cancer (change in bowel habit, absolute or recurrent constipation, rectal bleeding, significant weight loss or intestinal obstruction)
Patients diagnosed with colorectal cancer by imaging and histopathology
Disqualifiers
Age <18 years old.
Patients with past history of chemotherapy or surgical excision of tumor
Patients with familial adenomatous polyposis
Patients with hereditary non-polyposis colorectal cancer
Trial design
Treatments tested in this trial
- Serum level of Human Talin-1
- Serum level of Human Cripto-1
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov